Using integrated data to create a dimensional view of outcomes and cost
Integrating data at scale is growing easier with advances in de-identification software, development of certified data models to protect privacy, and cloud-based computing. The resulting value is a dimensional view of outcomes and cost. Traditional analysis leaves vital information out of the value equation.
Improve decisions, enrich research and strengthen strategies
Life sciences research is benefiting from the powerful addition of integrated data. Researchers can now gain data in sufficient amounts to power robust analytics. This white paper explores how this new data can improve early business decisions, enrich research activity and strengthen market strategies.
Related healthcare insights
Article
Cut through the noise of the Inflation Reduction Act of 2022 with key points aimed to help life sciences leaders leverage impactful data.
Article
See how the FDA and Optum use real-world evidence to monitor the safety and effectiveness of COVID-19 vaccines in our youngest populations.
Guide
As a key FDA collaborator, Optum Epidemiology generates reproducible results that inform regulatory decisions for COVID-19 vaccines.